Association between caffeine consumption and nonalcoholic fatty liver disease: a systemic review and meta-analysis (Q26771874)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26770272%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference

Association between caffeine consumption and nonalcoholic fatty liver disease: a systemic review and meta-analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26770272%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference

1 reference

1 reference

metabolic dysfunction–associated steatotic liver disease

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26770272%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

author name string

Huafeng Shen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26770272%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Andrea C Rodriguez

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26770272%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Seth Lipka

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26770272%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Ghulamullah Shahzad

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26770272%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Ambuj Kumar

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26770272%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Paul Mustacchia

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26770272%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

language of work or name

English

0 references

publication date

1 January 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26770272%20AND%20SRC:MED&resulttype=core&format=json

Therapeutic Advances in Gastroenterology

5 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26770272%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26770272%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

page(s)

113-120

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26770272%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26770272%20AND%20SRC:MED&resulttype=core&format=json

Association of coffee drinking with total and cause-specific mortality

5 March 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4699270

Measuring inconsistency in meta-analyses

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4699270

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

7 April 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4699270

7 April 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4699270

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4699270

Association between nonalcoholic fatty liver disease and colorectal adenoma: a systemic review and meta-analysis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4699270

Coffee consumption in NAFLD patients with lower insulin resistance is associated with lower risk of severe fibrosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4699270

Coffee and non-alcoholic fatty liver disease: brewing evidence for hepatoprotection?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4699270

Caffeine attenuates liver fibrosis via defective adhesion of hepatic stellate cells in cirrhotic model.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4699270

Caffeine intake, smoking, and risk of Parkinson disease in men and women

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4699270

Coffee consumption and prostate cancer risk and progression in the Health Professionals Follow-up Study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4699270

Caffeine (1, 3, 7-trimethylxanthine) in foods: a comprehensive review on consumption, functionality, safety, and regulatory matters

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4699270

Increased caffeine consumption is associated with reduced hepatic fibrosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4699270

Less Smad2 is good for you! A scientific update on coffee's liver benefits

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4699270

Review article: possible beneficial effects of coffee on liver disease and function

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4699270

Observational research methods. Research design II: cohort, cross sectional, and case-control studies

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4699270

Food sources and intakes of caffeine in the diets of persons in the United States

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4699270

Regular coffee but not espresso drinking is protective against fibrosis in a cohort mainly composed of morbidly obese European women with NAFLD undergoing bariatric surgery

31 May 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756283X15593700

Caffeine is protective in patients with non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756283X15593700

Coffee drinking and hepatocellular carcinoma risk: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756283X15593700

Protective role of coffee in non-alcoholic fatty liver disease (NAFLD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756283X15593700

Coffee induces expression of glucuronosyltransferases by the aryl hydrocarbon receptor and Nrf2 in liver and stomach

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756283X15593700

Beverage caffeine intakes in the U.S.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756283X15593700

Coffee and sweetened beverage consumption and the risk of type 2 diabetes mellitus: the atherosclerosis risk in communities study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756283X15593700

Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756283X15593700

High coffee intake is associated with lower grade nonalcoholic fatty liver disease: the role of peripheral antioxidant activity.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4699270

Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis

28 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26770272

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Reply to: "regular coffee: a magic bullet or a naked gun? Regular coffee but not espresso drinking is protective against fibrosis in NAFLD"

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26770272

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1177/1756283X15593700

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26770272%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26770272%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference